Abstract:Summary The gut and liver are recognized to mutually communicate through the biliary tract, portal vein, and systemic circulation . However, it remains unclear how this gut-liver axis regulates intestinal physiology. Through hepatectomy and transcriptomic and proteomic profiling, we identified pigment epithelium-derived factor (PEDF), a liver-derived soluble Wnt inhibitor, which restrains intestinal stem cell (ISC) hyperproliferation to maintain gut homeostasis by suppressing the Wnt/β-catenin signaling pathway. Furthermore, we found that microbial danger signals resulting from intestinal inflammation can be sensed by the liver, leading to the repression of PEDF production through peroxisome proliferator-activated receptor-α (PPARα). This repression liberates ISC proliferation to accelerate tissue repair in the gut. Additionally, treating mice with fenofibrate , a clinical PPARα agonist used for hypolipidemia, enhances colitis susceptibility due to PEDF activity. Therefore, we have identified a distinct role for PEDF in calibrating ISC expansion for intestinal homeostasis through reciprocal interactions between the gut and liver. Graphical abstract Download : Download high-res image (139KB) Download : Download full-size image

What problem does this paper attempt to address?

### The Problems Addressed by the Paper This paper explores how the interaction between the liver and the intestine regulates the proliferation of intestinal stem cells (ISC) and intestinal homeostasis. Specifically, the researchers aim to answer the following questions: 1. **How do factors secreted by the liver affect the proliferation of intestinal stem cells?** - The study found that pigment epithelium-derived factor (PEDF) secreted by the liver can inhibit the excessive proliferation of intestinal stem cells, thereby maintaining intestinal homeostasis. 2. **How does intestinal inflammation affect the production of PEDF through the liver?** - The research shows that the increased bacterial lipopolysaccharide (LPS) burden caused by intestinal inflammation can inhibit the production of PEDF through the peroxisome proliferator-activated receptor α (PPARα) signaling pathway in the liver, thereby releasing ISC proliferation and accelerating tissue repair. 3. **What is the role of PEDF in intestinal inflammation?** - The study found that the lack of PEDF can protect mice from intestinal inflammation, while the supplementation of PEDF exacerbates intestinal inflammation, leading to more severe tissue damage and impaired ISC proliferation. 4. **Through what mechanism does PEDF inhibit ISC proliferation?** - The research shows that PEDF inhibits ISC proliferation by binding to the Wnt receptor LRP5/6, thereby inhibiting the Wnt/β-catenin signaling pathway. ### Main Conclusions - **The liver regulates ISC proliferation by secreting PEDF**: PEDF limits the excessive proliferation of ISC by inhibiting the Wnt/β-catenin signaling pathway, maintaining intestinal homeostasis. - **Intestinal inflammation affects liver PEDF production through LPS**: The increase in LPS caused by intestinal inflammation inhibits the production of PEDF in the liver through the PPARα signaling pathway, thereby releasing ISC proliferation and promoting tissue repair. - **The dual role of PEDF in intestinal inflammation**: The lack of PEDF can protect mice from intestinal inflammation, while the supplementation of PEDF exacerbates intestinal inflammation, leading to more severe tissue damage and impaired ISC proliferation. These findings provide new insights into the interaction between the intestine and the liver and its impact on intestinal homeostasis and inflammation, and may offer potential molecular targets for the treatment of intestinal inflammation.

Gut-liver axis calibrates intestinal stem cell fitness

A gut–liver axis in intestinal stem cell fitness

The Gut Microbiome and Intestinal Failure-Associated Liver Disease

Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases

A Role for Intestinal Alkaline Phosphatase in Preventing Liver Fibrosis

Variation in the Gut Microbial Community is Associated with the Progression of Liver Regeneration

Very long-chain fatty acids control peroxisome dynamics via a feedback loop in intestinal stem cells during gut regeneration

Gut-liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism

GDF2 and BMP10 coordinate liver cellular crosstalk to maintain liver health

Single-cell transcriptomics reveals intestinal cell heterogeneity and identifies Ep300 as a potential therapeutic target in mice with acute liver failure

Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling

Transcriptional Integration of Distinct Microbial and Nutritional Signals by the Small Intestinal Epithelium

Regulation of Hepatic Lipid Metabolism by Intestine Epithelium-Derived Exosomes

Intestinal Inflammation Alters the Expression of Hepatic Bile Acid Receptors Causing Liver Impairment

Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice

Gut–liver axis: barriers and functional circuits

Endothelial force sensing signals to parenchymal cells to regulate bile and plasma lipids

The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration

Liver Injury Impaired 25-Hydroxylation of Vitamin D Suppresses Intestinal Paneth Cell defensins, leading to Gut Dysbiosis and Liver Fibrogenesis

The liver–brain–gut neural arc maintains the Treg cell niche in the gut

Gut-liver Axis: Gut Microbiota in Shaping Hepatic Innate Immunity